Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical and Experimental Immunology|April 26, 2006
Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levelsF Bolacchi, A Sinistro, C Ciaprini, et al.
Clinical and Experimental Immunology|May 5, 1998
HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophagesA Bergamini, F Bolacchi, E Faggioli, et al.
The Journal of Infectious Diseases|March 9, 1999
Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1A Bergamini, E Faggioli, F Bolacchi, et al.
Hepatology (Baltimore, Md.)|April 1, 1997
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cellsA Bergamini, L Dini, L Baiocchi, et al.
Clinical and Experimental Immunology|April 12, 2001
Lack of evidence for the Th2 predominance in patients with chronic hepatitis CA Bergamini, F Bolacchi, G Cerasari, et al.
Clinical and Experimental Immunology|April 12, 2001
Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis CA Bergamini, F Bolacchi, M Cepparulo, et al.
Antiviral Chemistry & Chemotherapy|May 20, 2000
Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agentsG Campiani, M Fabbrini, E Morelli, et al.
Journal of Medicinal Chemistry|November 2, 1999
Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activityG Campiani, E Morelli, M Fabbrini, et al.
Journal of Medicinal Chemistry|July 21, 2001
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agentG Campiani, F Aiello, M Fabbrini, et al.
Pageof 3